CI Share Price | The Cigna Group Stock Analysis & Recommendation

Q: What does The Cigna Group do?

Overview:The Cigna Group is a health services company that operates in the Healthcare Services industry and falls within the large-cap market category.Financial Snapshot:Most recent Net Profit: 1,409 Million (Quarterly Results - Mar 2025) Market-cap: USD 94,580.40 Million (Large Cap)Key Metrics:P/E: 16.00 Dividend Yield: 1,079.04% Debt Equity: -0.13 Return on Equity: 14.33% Price to Book: 2.35Contact Details:Address: 900 Cottage Grove Rd, BLOOMFIELD CT: 06002-2920 Tel: ['1 860 2266000', '1 215 7614198'] Fax: 1 302 6555049 Website: https://www.cigna.com/

Q: Who are in the management team of The Cigna Group?

As of March 2022, the management team of The Cigna Group includes the following individuals:- Mr. Isaiah Harris, Independent Chairman of the Board- Mr. David Cordani, Chief Executive Officer and Director- Ms. Kimberly Ross, Director- Mr. William DeLaney, Independent Director- Mr. Eric Foss, Independent Director- Maj. Gen. Elder Granger, Independent Director- Ms. Kathleen Mazzarella, Independent DirectorThis team is responsible for guiding the company's strategic direction and overseeing its operations.

Q: Is The Cigna Group overvalued or undervalued?

As of 7 July 2025, The Cigna Group's valuation grade has moved from fair to expensive, indicating a shift towards being overvalued. The company is currently assessed as overvalued based on its P/E ratio of 16, which is higher than its peers, such as UnitedHealth Group at 13.13 and Elevance Health at 12.97. Additionally, the EV to EBITDA ratio stands at 33.02, significantly above the industry average, while the PEG ratio of 0.41 suggests that the stock may not be growing at a pace that justifies its current valuation.In terms of performance, The Cigna Group has underperformed relative to the S&P 500 over several periods, with a 1-year return of -17.34% compared to the S&P 500's 17.14%. This trend reinforces the notion that the stock may be overvalued, as it has not delivered returns commensurate with its price. Overall, the combination of high valuation ratios and poor recent performance suggests that The Cigna Group is currently overvalued.

Q: Is The Cigna Group technically bullish or bearish?

As of 31 October 2025, the technical trend for The Cigna Group has changed from mildly bearish to bearish. The current stance is bearish with a weak strength indicated by the weekly MACD and moving averages both showing bearish signals. The monthly MACD is also bearish, while the RSI shows a bullish signal on the monthly timeframe but no signal on the weekly. Bollinger Bands and Dow Theory are both mildly bearish across weekly and monthly periods. In terms of performance, The Cigna Group has underperformed compared to the S&P 500 across multiple periods, with a 1-year return of -16.38% versus the S&P 500's 19.89%, and a 3-year return of -18.38% compared to 76.66% for the index.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

381.32 k

Shareholding (Sep 2025)

FII

16.52%

Held by 488 FIIs

DII

45.68%

Held by 64 DIIs

Promoter

0.00%

How big is The Cigna Group?

22-Jun-2025

As of Jun 18, The Cigna Group has a market capitalization of $94.58 billion, with net profit of $5.40 billion and total assets of $151.50 billion.

View full answer

What does The Cigna Group do?

22-Jun-2025

The Cigna Group is a large-cap health services company specializing in healthcare services, with a recent net profit of $1.41 billion and a market capitalization of approximately $94.58 billion. Key metrics include a P/E ratio of 16.00 and a return on equity of 14.33%.

View full answer

Who are in the management team of The Cigna Group?

22-Jun-2025

As of March 2022, The Cigna Group's management team includes Mr. Isaiah Harris (Independent Chairman), Mr. David Cordani (CEO), and several independent directors: Ms. Kimberly Ross, Mr. William DeLaney, Mr. Eric Foss, Maj. Gen. Elder Granger, and Ms. Kathleen Mazzarella. They oversee the company's strategic direction and operations.

View full answer

Is The Cigna Group overvalued or undervalued?

20-Sep-2025

As of July 7, 2025, The Cigna Group is considered overvalued due to a high P/E ratio of 16 compared to peers, an elevated EV to EBITDA ratio of 33.02, and poor performance with a 1-year return of -17.34% versus the S&P 500's 17.14%.

View full answer

Is The Cigna Group technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, The Cigna Group's technical trend is bearish with weak strength indicators, underperforming the S&P 500 significantly over the past year and three years.

View full answer

Compare The Cigna Group with Similar Stocks

Elevance Health, Inc.UnitedHealth Group, Inc.Humana, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 14.25%

Positive results in Jun 25

With ROE of 14.33%, it has a expensive valuation with a 2.35 Price to Book Value

Mojo Parameters

Stock DNA

Industry

Healthcare Services

Market cap

USD 73,436 Million (Large Cap)

P/E

16.00

Industry P/E

Dividend Yield

1,460.68%

Debt Equity

-0.09

Return on Equity

16.45%

Price to Book

1.76

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

1,632 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

2.66%

6 Months

1.92%

1 Year

-6.78%

2 Years

-16.1%

3 Years

-7.14%

4 Years

22.74%

5 Years

32.3%

The Cigna Group for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

11.06%

EBIT Growth (5y)

143.16%

EBIT to Interest (avg)

0.67

Debt to EBITDA (avg)

9.18

Net Debt to Equity (avg)

0.10

Sales to Capital Employed (avg)

3.71

Tax Ratio

21.04%

Dividend Payout Ratio

46.19%

Pledged Shares

Institutional Holding

86.27%

ROCE (avg)

1.70%

ROE (avg)

14.25%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.35

EV to EBIT

EV to EBITDA

33.02

EV to Capital Employed

2.54

EV to Sales

0.35

PEG Ratio

0.41

Dividend Yield

1080.18%

ROCE (Latest)

ROE (Latest)

14.33%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 189 Schemes (37.75%)

Foreign Institutions

Held by 488 Foreign Institutions (16.52%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.18% vs 7.88% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "682.00",
          "val2": "738.00",
          "chgp": "-7.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "337.00",
          "val2": "375.00",
          "chgp": "-10.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-74.00",
          "val2": "-63.00",
          "chgp": "-17.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,632.00",
          "val2": "1,629.00",
          "chgp": "0.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "36.20%",
          "val2": "40.10%",
          "chgp": "-0.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -29.67% vs -20.79% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,775.00",
          "val2": "3,028.00",
          "chgp": "-8.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1,435.00",
          "val2": "1,446.00",
          "chgp": "-0.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-275.00",
          "val2": "-498.00",
          "chgp": "44.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,778.00",
          "val2": "5,372.00",
          "chgp": "-29.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.50%",
          "val2": "45.90%",
          "chgp": "-1.74%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

682.00

738.00

-7.59%

Interest

337.00

375.00

-10.13%

Exceptional Items

-74.00

-63.00

-17.46%

Consolidate Net Profit

1,632.00

1,629.00

0.18%

Operating Profit Margin (Excl OI)

36.20%

40.10%

-0.39%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 0.18% vs 7.88% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

2,775.00

3,028.00

-8.36%

Interest

1,435.00

1,446.00

-0.76%

Exceptional Items

-275.00

-498.00

44.78%

Consolidate Net Profit

3,778.00

5,372.00

-29.67%

Operating Profit Margin (Excl OI)

28.50%

45.90%

-1.74%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -29.67% vs -20.79% in Dec 2023

All Annual Results

Company CV

About The Cigna Group

The Cigna Group

Healthcare Services

Cigna Corporation is a health services company that offers medical, dental insurance and related products and services. The Company's segments are Evernorth, U.S. Medical and International Markets. The Company's Evernorth segment is engaged in offering coordinated and point solution health services, including pharmacy services, benefits management, care solutions and data and analytics, which are provided to health plans, employers, government organizations, and health care providers. Its U.S. Medical segment offers U.S. Commercial and U.S. Government health care solutions to employers and individuals. Its International Markets includes supplemental health care coverage in international markets, as well as health care benefits to globally mobile employees of multinational organizations.

Company Coordinates

Company Details

900 Cottage Grove Rd , BLOOMFIELD CT : 06002-2920

Tel: 1 860 22660001 215 7614198

https://www.cigna.com/

Registrar Details

The Cigna Group

1Day

52 Week

CASH

FII

DII

Promoter

How big is The Cigna Group?

Watch in Real-Time

What does The Cigna Group do?

Who are in the management team of The Cigna Group?

Is The Cigna Group overvalued or undervalued?

Is The Cigna Group technically bullish or bearish?

Compare The Cigna Group with Similar Stocks

MarketsMojo — Loved in India, Now Global

Dashboard

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 14.25%

Positive results in Jun 25

With ROE of 14.33%, it has a expensive valuation with a 2.35 Price to Book Value

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About The Cigna Group

Company Coordinates